Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

Clinical trial NCT04504370 · COMPLETED

Trial details

NCT number: NCT04504370
Sponsor: PegBio Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus (T2DM)

Start date: 2020-04-27
Primary completion: 2022-03-30
Enrollment: 273

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.